The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Unsensitized guinea-pig erythrocytes (Egp) were lysed by a combination of eight isolated, human-derived complement components, Cls, C4, C2, C5, C6, C7, C8 and C9 (Cls-C9exC3), even in the presence of anti-C3. It was determined that a factor was generated in the reaction mixture of Cls, C4, C2, C5 and C6, which had a lytic activity against Egp when C7, C8 and C9 were added. The lytic factor was similar to C56 in the following properties: the activity of the lytic factor decreased when incubated with C7 prior to its reaction with Egp, the lytic factor did not bind to Egp by itself but it did bind in the presence of C7, EDTA did not have any inhibitory effect on the lytic factor, and the activity of the lytic factor was lost by treatment with anti-C5 or anti-C6 but not by treatment with anti-C4. Furthermore, C5a, a cleavage product of C5, was clearly detected in the reaction mixture of Cls, C4, C2 and C5. These findings indicate that C5 can be activated proteolytically into C5a and C5b in the fluid phase solely by the classical pathway C3 convertase, C42, without any participation of C3.
D000818:Animals; D000906:Antibodies / Q000276:immunology; D003167:Complement Activation; D003176:Complement C3 / Q000037:antagonists & inhibitors / Q000276:immunology*; D003182:Complement C5 / Q000276:immunology*; D003171:Complement Pathway, Classical; D003165:Complement System Proteins / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D004912:Erythrocytes / Q000276:immunology; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D008274:Magnesium / Q000276:immunology
D000906:Antibodies; D003176:Complement C3; D003182:Complement C5; D003165:Complement System Proteins; D008274:Magnesium